5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.68▼ | 4.81▼ | 4.81▼ | 5.44▼ | 4.52▲ |
MA10 | 5.01▼ | 5.09▼ | 5.09▼ | 5.12▼ | 3.80▲ |
MA20 | 5.26▼ | 5.49▼ | 5.56▼ | 4.45▲ | 3.56▲ |
MA50 | 5.73▼ | 5.73▼ | 5.25▼ | 3.58▲ | 12.84▼ |
MA100 | 5.81▼ | 5.21▼ | 4.54▲ | 3.53▲ | 31.89▼ |
MA200 | 5.44▼ | 4.17▲ | 3.81▲ | 9.89▼ | 46.42▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.071▼ | -0.118▼ | -0.162▼ | 0.039▲ | 1.028▲ |
RSI | 23.474▼ | 26.169▼ | 31.138▼ | 53.895▲ | 41.368▼ |
STOCH | 4.424▼ | 3.040▼ | 2.485▼ | 47.725 | 62.539 |
WILL %R | -97.790▼ | -98.381▼ | -98.639▼ | -70.967 | -56.307 |
CCI | -104.221▼ | -128.081▼ | -122.103▼ | -8.191 | 143.667▲ |
Tuesday, June 10, 2025 05:00 PM
With these results, the firm believes BioLineRx will have additional opportunities to eithe BioLineRx Ltd’s (NASDAQ:BLRX) poster, which includes new data from the single-arm pilot phase of the ...
|
Friday, June 06, 2025 11:29 AM
With earnings season wrapping up, some analysts have discovered they were too bearish on a company. That causes them to upgrade the stock, which usually comes with a higher price target. But some ...
|
Friday, June 06, 2025 11:29 AM
BioLineRx Ltd. (NASDAQ: BLRX) is a commercial stage biopharmaceutical company that develops and commercializes therapeutics for oncology and rare diseases. The company’s mulitiple myeloma drug ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 5.18 | 5.2665 | 4.5264 | 4.69 | 166,126 |
12/06/25 | 5.11 | 5.3974 | 5.10 | 5.29 | 145,854 |
11/06/25 | 5.54 | 5.936 | 5.30 | 5.44 | 258,338 |
10/06/25 | 5.92 | 6.445 | 5.73 | 5.84 | 406,987 |
09/06/25 | 6.32 | 6.32 | 5.92 | 5.93 | 590,537 |
06/06/25 | 5.17 | 6.4499 | 5.08 | 5.74 | 969,512 |
05/06/25 | 4.65 | 5.50 | 4.49 | 5.27 | 274,697 |
04/06/25 | 4.06 | 4.73 | 4.00 | 4.655 | 269,140 |
03/06/25 | 4.03 | 4.47 | 3.8821 | 4.22 | 336,613 |
02/06/25 | 5.16 | 5.23 | 4.05 | 4.10 | 734,870 |
|
|
||||
|
|
||||
|
|